These effects of AVID200 on Gata1lo and absence of TGF-β insensitivity in the Gata1lo mouse might reflect the absence of MPN driver mutations in this MF mouse model or an effect of the drug on HSC/HPC trafficking between the spleen and the marrow. This evidence concerns the gene TGFB1 and myeloproliferative disorder.